Numerous studies demonstrated an importance of cytochrome P-450 epoxygenase pathway of arachidonic acids metabolism for the pathogenesis of essential hypertension (EH). The present study was designed to investigate whether common single-nucleotide polymorphisms (SNP) of CYP2C gene subfamily such as CYP2C8 (rs7909236 and rs1934953), CYP2C9 (rs9332242), and CYP2C19 (rs4244285) are associated with susceptibility to EH in Russian population. A total of 816 unrelated Russian individuals comprising 425 EH patients and 391 normotensive controls were included into the study. Genotyping of SNPs was performed using the MassARRAY 4 system. SNP rs7909236 of CYP2C8 was significantly associated with increased risk of EH (OR adjusted for sex and age was 2.99 95% CI 1.39-6.44, P = 0.005). SNPs rs1934953 CYP2C8 and rs4244285 of CYP2C19 showed association with EH risk but at a borderline statistical significance (P ≤ 0.04). Combination of genotypes CYP2C8 rs7909236 TT and CYP2C19 rs4244285 GG was associated with increased EH risk (OR 3.34 95%CI 1.48-7.51, P = 0.004). Genotype-phenotype correlation analysis showed that the levels of CYP2C8 mRNA were significantly correlated with SNP rs7909236 (P = 0.01). in silico functional prediction analysis revealed the functionality of majority of investigated SNPs. Thus, genes of CYP2C subfamily are important genetic determinants of susceptibility to essential hypertension in Russians.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10641963.2016.1246562DOI Listing

Publication Analysis

Top Keywords

cyp2c gene
8
gene subfamily
8
epoxygenase pathway
8
pathway arachidonic
8
arachidonic acids
8
acids metabolism
8
susceptibility russian
8
russian population
8
essential hypertension
8
cyp2c8 rs7909236
8

Similar Publications

CYP2C gene polymorphisms in North African populations.

Mol Biol Rep

November 2024

Laboratory of Genetics, Immunology and Human Pathologies, Faculty of Sciences of Tunis, University of Tunis El Manar, 2092, Tunis, Tunisia.

Background: Cytochrome P450 is a superfamily of genes generating hemoproteins that metabolize foreign chemicals as well as endogenous compounds, such as steroids. The human CYP2C genes (CYP2C8, CYP2C9, CYP2C18, CYP2C19) cluster on chromosome 10 and metabolize many clinically useful drugs. CYP2C19 and CYP2C9 have been the most studied while CYP2C8 has been studied less frequently.

View Article and Find Full Text PDF
Article Synopsis
  • The Association for Molecular Pathology's Pharmacogenomics Working Group aims to establish key attributes and a standard set of genetic variants for clinical pharmacogenetic testing.
  • The document outlines two tiers of recommended genetic variants, which will guide clinical laboratories in creating pharmacogenomics assays.
  • Focused on dihydropyrimidine dehydrogenase (DPYD) testing, the recommendations encourage standardization while serving as a flexible reference rather than strict rules.
View Article and Find Full Text PDF

The Effect of CYP2C19*2 (rs4244285) and CYP17 (rs743572) SNPs on Adriamycin and Paclitaxel based Chemotherapy Outcomes in Breast Cancer Patients.

Asian Pac J Cancer Prev

June 2024

Department of Molecular Biology and Genetics, Krishna Institute of Allied Sciences, Krishna Vishwa Vidyapeeth (Deemed to be University), Taluka-Karad, Dist- Satara, Pin-415 539, (Maharashtra) India.

Background: Cytochrome P450 (CYP) are phase I metabolizing enzymes involved in detoxification of chemotherapeutic agents. Among the CYP gene family, including CYP1A1, CYP1B1, CYP2C, CYP2D, CYP2E and CYP17, their significance in cancer susceptibility is well established. However, there remains limited understanding regarding the polymorphisms of CYP2C19*2 and CYP17 and their potential correlation with chemotherapy-induced toxicity reactions in breast cancer (BC) patients.

View Article and Find Full Text PDF

Is Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Genes (Basel)

May 2024

Department of Medical Chemistry, Biochemistry and Clinical Chemistry, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

Article Synopsis
  • A recently identified haplotype influences the ultrarapid metabolism of CYP2C19 substrates, impacting the activation of the platelet inhibitor clopidogrel.
  • Patients with poor or intermediate CYP2C19 metabolism have a higher risk of ischemic events, while those with normal or ultrarapid metabolism experience lower risks.
  • In a study of 283 clopidogrel-treated adults, no significant impact of the haplotype on the efficacy and bleeding risk of clopidogrel was observed, as both ischemic and bleeding events were relatively similar across different phenotype groups.
View Article and Find Full Text PDF
Article Synopsis
  • Pharmacogenomic testing is increasingly important for psychiatric care, but more research is needed to understand its practical benefits in real-world settings.
  • A study involving 15,000 patients revealed that 65% had potentially actionable genetic traits related to drug metabolism, particularly for the genes CYP2C19 and CYP2D6, with 87% showing some potential for actionable insights.
  • The use of advanced genetic sequencing helped identify significant genetic variations that could affect treatment decisions, suggesting that early pharmacogenomic testing might improve medication prescribing and patient outcomes in psychiatric care.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!